Literature DB >> 27158939

Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.

Luis M Blancas-Mejía1, Marina Ramirez-Alvarado1.   

Abstract

Light chain amyloidosis is a protein misfolding disease in which immunoglobulin light chains aggregate as insoluble fibrils that accumulate in extracellular deposits. Amyloid fibril formation in vitro has been described as a nucleation-polymerization, autocatalytic reaction in which nascent fibrils catalyze formation of new fibrils, recruiting soluble protein into the fibril. In this context, it is also established that preformed fibrils or "seeds" accelerate fibril formation. In some cases, seeds with a substantially different sequence are able to accelerate the reaction, albeit with a lower efficiency. In this work, we studied the recruitment and addition of monomers in the presence of seeds of five immunoglobulin light chain proteins, covering a broad range of protein stabilities and amyloidogenic properties. Our data reveal that in the presence of homologous or heterologous seeds, the fibril formation reactions become less stochastic than de novo reactions. The kinetics of the most amyloidogenic proteins (AL-T05 and AL-09) do not present significant changes in the presence of seeds. Amyloidogenic protein AL-103 presented fairly consistent acceleration with all seeds. In contrast, the less amyloidogenic proteins (AL-12 and κI) presented dramatic differential effects that are dependent on the kind of seed used. κI had a poor efficiency to elongate preformed fibrils. Together, these results indicate that fibril formation is kinetically determined by the conformation of the amyloidogenic precursor and modulated by the differential ability of each protein to either nucleate or elongate fibrils. We observe morphological and conformational properties of some seeds that do not favor elongation with some proteins, resulting in a delay in the reaction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27158939      PMCID: PMC4968207          DOI: 10.1021/acs.biochem.6b00090

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Kinetic analysis of amyloid fibril formation.

Authors:  H Naiki; F Gejyo
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.

Authors:  Ara Celi DiCostanzo; James R Thompson; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

3.  The monomer-seed interaction mechanism in the formation of the β2-microglobulin amyloid fibril clarified by solution NMR techniques.

Authors:  Kotaro Yanagi; Kazumasa Sakurai; Yuichi Yoshimura; Tsuyoshi Konuma; Young-Ho Lee; Kenji Sugase; Takahisa Ikegami; Hironobu Naiki; Yuji Goto
Journal:  J Mol Biol       Date:  2012-06-06       Impact factor: 5.469

4.  Amylin deposition in the brain: A second amyloid in Alzheimer disease?

Authors:  Kaleena Jackson; Gustavo A Barisone; Elva Diaz; Lee-way Jin; Charles DeCarli; Florin Despa
Journal:  Ann Neurol       Date:  2013-07-12       Impact factor: 10.422

5.  Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.

Authors:  Luis M Blancas-Mejía; Alexander Tischer; James R Thompson; Jonathan Tai; Lin Wang; Matthew Auton; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2013-10-22       Impact factor: 5.469

6.  Transfer amyloidosis. I. Studies on the transfer of various lymphoid cells from amyloidotic mice to syngeneic nonamyloidotic recipients. II. Induction of amyloidosis in mice with spleen, thymus and lymph node tissue from casein-sensitized syngeneic donors.

Authors:  F Hardt
Journal:  Am J Pathol       Date:  1971-11       Impact factor: 4.307

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.

Authors:  Francesca Lavatelli; David H Perlman; Brian Spencer; Tatiana Prokaeva; Mark E McComb; Roger Théberge; Lawreen H Connors; Vittorio Bellotti; David C Seldin; Giampaolo Merlini; Martha Skinner; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2008-05-12       Impact factor: 5.911

Review 9.  Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases.

Authors:  Rodrigo Morales; Ines Moreno-Gonzalez; Claudio Soto
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

10.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.

Authors:  Samuel I A Cohen; Sara Linse; Leila M Luheshi; Erik Hellstrand; Duncan A White; Luke Rajah; Daniel E Otzen; Michele Vendruscolo; Christopher M Dobson; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-23       Impact factor: 11.205

View more
  12 in total

1.  Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.

Authors:  Luis M Blancas-Mejía; Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2017-01-24       Impact factor: 3.162

2.  Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.

Authors:  Luis M Blancas-Mejía; Emily B Martin; Angela Williams; Jonathan S Wall; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2017-09-01       Impact factor: 2.352

3.  Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.

Authors:  Pinaki Misra; Luis M Blancas-Mejia; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2019-07-09       Impact factor: 3.162

4.  Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.

Authors:  Kathrin Andrich; Ute Hegenbart; Christoph Kimmich; Niraja Kedia; H Robert Bergen; Stefan Schönland; Erich Wanker; Jan Bieschke
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

5.  Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.

Authors:  Marta Marin-Argany; Yi Lin; Pinaki Misra; Angela Williams; Jonathan S Wall; Kyle G Howell; Laura R Elsbernd; Megan McClure; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

Review 6.  Immunoglobulin light chain amyloid aggregation.

Authors:  Luis M Blancas-Mejia; Pinaki Misra; Christopher J Dick; Shawna A Cooper; Keely R Redhage; Michael R Bergman; Torri L Jordan; Khansaa Maar; Marina Ramirez-Alvarado
Journal:  Chem Commun (Camb)       Date:  2018-09-20       Impact factor: 6.222

7.  Assays for Light Chain Amyloidosis Formation and Cytotoxicity.

Authors:  Luis M Blancas-Mejia; Pinaki Misra; Christopher J Dick; Marta Marin-Argany; Keely R Redhage; Shawna A Cooper; Marina Ramirez-Alvarado
Journal:  Methods Mol Biol       Date:  2019

8.  Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.

Authors:  Emily B Martin; Angela Williams; Craig Wooliver; R Eric Heidel; Sarah Adams; John Dunlap; Marina Ramirez-Alvarado; Luis M Blancas-Mejia; Ronald H Lands; Stephen J Kennel; Jonathan S Wall
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

9.  2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis .

Authors:  Mark Renz; Ronald Torres; Philip J Dolan; Stephen J Tam; Jose R Tapia; Lauri Li; Joshua R Salmans; Robin M Barbour; Paul J Shughrue; Tarlochan Nijjar; Dale Schenk; Gene G Kinney; Wagner Zago
Journal:  Amyloid       Date:  2016-08-05       Impact factor: 7.141

10.  Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.

Authors:  Tejaswini Pradhan; Karthikeyan Annamalai; Riddhiman Sarkar; Stefanie Huhn; Ute Hegenbart; Stefan Schönland; Marcus Fändrich; Bernd Reif
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.